Professor Christopher (Chris) Nolan is a clinician-scientist working in the field of diabetes, including diabetes in pregnancy. He is Professor of Endocrinology at the Australian National University and a Senior Staff Specialist in Diabetes and Endocrinology at The Canberra Hospital. Under his leadership as Director of Diabetes Services (2011-2018), the ACT Health Diabetes Service was recognised as a National Centre of Excellence by the National Association of Diabetes Centres. His research activities traverse basic science, clinical science and public health. A few of his key discoveries include the feto-placental glucose steal phenomenon, the glycerolipid fatty acid cycle in islet beta-cells, major pre-analytical issues with laboratory measurement of glucose impacting gestational diabetes (GDM) diagnosis, and the benefits of early diagnosis and treatment of GDM in at risk women. Current projects include the investigation of insulin hypersecretion and how to reverse it in the prevention and management of type 2 diabetes, the utility of the Objective FieldAnalyszer for diabetic eye disease, and the development of a novel breath ketone monitor. He is currently a Board Member of the Australian Diabetes Society, Chair of the National Association of Diabetes Centres Steering Committee, and Co-Chair of the Program Organizing Committee for the IDF-WPR/ ADC/ Metabolic Diseases 2026 Congress.

Weiping Han obtained his PhD at Cornell University and did postdoctoral work at the University of Pittsburgh and HHMI/UT Southwestern Medical Center. Currently he is Distinguished Principal Scientist at the Institute of Molecular and Cell Biology (A*STAR), Professor at National University of Singapore and Duke-NUS Medical School, and a Member of the Neurobiology Program at Life Sciences Institute of the National University of Singapore School of Medicine. His research interest centers around metabolic homeostasis in health and disease.

Li Ern is a second-year PhD candidate in the David James Lab at The University of Sydney. Her research aims to uncover the molecular mechanisms that cause selective impairments in GLUT4 trafficking, a key process disrupted in insulin resistance.

Dr Simon Bond is a cardiometabolic disease researcher investigating the molecular mechanisms underlying mitochondrial dysfunction and activation of the Integrated Stress Response. His work integrates novel pre-clinical models with mechanistic approaches to elucidate maladaptive stress signalling in cardiometabolic disease and identify potential therapeutic targets.